Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition After Elective Coronary Stenting

NCT00302913 is registered in ClinicalTrials.gov with University Heart Center Freiburg - Bad Krozingen as lead sponsor.

NCT NCT00302913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition After Elective Coronary Stenting
Lead sponsor
University Heart Center Freiburg - Bad Krozingen
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2005
Completion date
June 30, 2006
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, drug resistance